Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Status:
RECRUITING
Trial end date:
2031-12-31
Target enrollment:
Participant gender:
Summary
The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.